Active Implantable Medical Devices Market to Reach US$ 39,026.9 Million at CAGR of 7.9% by 2025 | The Insight Partners

Active Implantable Medical Devices Market to 2025 - Global Analysis and Forecasts By Product (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders, Neurostimulators, and Implantable Hearing Devices), End-User (Hospitals, Ambulatory Surgery Centers, and Specialty Clinics) and Geography

Publication Month: Oct 2018 | Report Code: TIPMD00002232 | No. of Pages: 144 | Category: Medical Device | Status: Published

The global active implantable medical devices market accounted to US$ 39,026.9 Mn in 2017 and is expected to grow at a CAGR of 7.9% during the forecast period 2018 - 2025, to account to US$ 22,096.9 Mn by 2025.

Europe is was the second largest geographic market and it is expected to be the second highest revenue contributor throughout the forecast period. Europe market is driven by the factors such as frequent product launches and increasing awareness among the population in the region. Additionally, rising chronic conditions and increasing government initiatives for healthcare are some major factors have that influence the European active implantable medical devices market.

Exhibit: Lucrative Regional Markets


 

Market Insights

Technological Advancements and New Product Launches

The active implantable medical devices is an emerging field in the medical industry and has led to various developments of the products, in the field of cardiology, neurology and otology. Many of the market players are developing novel products in order to minimize the burden of cardiovascular diseases, neurological disorders and hearing disorders. For instance, Boston Scientific Corporation in September 2017, launched the Resonate family of Implantable Cardioverter Defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. This product is powered by EnduraLife battery technology, which has double battery capacity as compared to other devices. Thus increasing the longevity of devices and managing heart failure more efficiently.

 

Increasing Burden of Cardiovascular Diseases, Neurological Disorders and Hearing Disorders

Active implantable devices like pacemakers, cochlear implants, ventricular assist devices, spinal cord stimulators and others are used to treat cardiovascular diseases, neurological disorders and hearing disorders. Thus the increasing prevalence of cardiovascular diseases, neurological disorders and hearing disorders is expected to drive market growth during the forecast period. According to the World health organization in 2017, cardiovascular diseases are number 1 cause of death all over the world. It also mentioned that in 2016, 17.9 million people across the globe died due to cardiovascular diseases.

 

Product Insights

The global active implantable medical devices market by product was led by implantable cardioverter defibrillators. In 2017, the implantable cardioverter defibrillators held a largest market share of 30.9% of the active implantable medical devices market, by product. The implantable cardioverter defibrillators segment is expected to dominate the market in 2025 owing to the rising prevalence of arrhythmia, enhances the growth of implantable cardioverter defibrillators. Atrial fibrillation (AF) is the most common type arrhythmia observed among the population, which may further lead to stroke, heart failure and other heart-related complications. This segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

 

End User Insights

The active implantable medical devices market by end user is segmented into hospitals, ambulatory surgery centers and specialty clinics. The hospitals segment is anticipated to grow at a CAGR of 8.1% during the forecast period. The increasing adoption of new technology devices in the hospitals and rising hospital research drives the market growth.

 

Exhibit: Active Implantable Medical Devices Market, by End User


 

Strategic Insights

Approvals and agreements were observed as the most adopted strategy in global active implantable medical devices industry. Few of the recent product launch and collaboration and others are listed below;

 

2018: In August, 2018, Abbott received FDA approval for software upgrade for its Infinity implants used to treat Parkinson’s and essential tremor full-body MRI compatibility.

2017: In November, 2017, Medtronic received CE (Conformité Européenne) Mark for the world's smallest fully implantable spinal cord stimulator. The neurostimulator is placed under patient’s skin in order to deliver mild electrical impulses through a lead implanted in the epidural space, which act to block pain signals from going to the brain.

2016: In November 2016, BIOTRONIK today announced the launch of Inventra HF-T, implantable cardioverter defibrillator (ICD) that delivers an ultra-high energy with 42 joules (J) on the first shock. Thus providing technologically advanced products that improve patient lives.

 

ACTIVE IMPLANTABLE MEDICAL DEVICES – MARKET SEGMENTATION

 

By Product

  • Implantable Cardioverter Defibrillators 
    • Transvenous Implantable Cardioverter Defibrillators
    • Subcutaneous Implantable Cardioverter Defibrillators
  • Implantable Cardiac Pacemakers
  • Neurostimulators
  • Implantable Hearing Devices
  • Ventricular Assist Devices
  • Implantable Heart Monitors/Insertable Loop Recorders

 

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Speciality Clinics

 

By Geography

•   North America

  • U.S.
  • Canada
  • Mexico

•   Europe

  • France
  • Germany
  • UK

•   Asia Pacific (APAC)

  • China
  • India
  • Japan

•   Middle East & Africa (MEA)

  • Saudi Arabia
  • South Africa
  • UAE

•   South America (SAM)

  • Brazil

 

Company Profiles

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • BIOTRONIK
  • LivaNova PLC
  • Cochlear Ltd.
  • MED-EL, Sonova
  • William Demant Holding A/S
  • Nurotron Biotechnology Co., Ltd

 

TABLE OF CONTENTS

1. INTRODUCTION 19
1.1 SCOPE OF THE STUDY 19
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 19

2. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET – KEY TAKEAWAYS 20

3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET – MARKET LANDSCAPE 23
3.1 OVERVIEW 23
3.2 MARKET SEGMENTATION 23
3.2.1 Global Active Implantable Medical Devices Market – By Product 24
3.2.2 Global Active Implantable Medical Devices Market – By End User 24
3.2.3 Global Active Implantable Medical Devices Market – By Geography 25
3.3 PEST ANALYSIS 26
3.3.1 North America – PEST Analysis 26
3.3.2 Europe – PEST Analysis 28
3.3.3 Middle East and Africa – PEST Analysis 32
3.3.4 South and Central America – PEST Analysis 34

4. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET – KEY MARKET DYNAMICS 36
4.1 KEY MARKET DRIVERS 36
4.1.1 Increasing Burden of Cardiovascular Diseases, Neurological Disorders and hearing disorders 36
4.1.2 Technological Advancements and New Product Launches 36
4.1.3 Large pool of geriatric population 36
4.2 KEY MARKET RESTRAINTS 37
4.2.1 High Cost of Products and Procedures 37
4.2.2 High Rate of Product Recalls 37
4.3 KEY MARKET OPPORTUNITIES 38
4.3.1 Growing Healthcare Market In The Developing Economies 38
4.4 FUTURE TRENDS 38
4.4.1 Growing product innovations 38
4.5 IMPACT ANALYSIS 39

5. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET –GLOBAL ANALYSIS 40
5.1 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE FORECASTS AND ANALYSIS 40
5.2 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 41
5.3 EXPERT OPINIONS 41

6. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET ANALYSIS– BY PRODUCT 43
6.1 OVERVIEW 43
6.2 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES, BY PRODUCT 2017 & 2025 (%) 43
6.3 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET 44
6.3.1 Overview 44
6.3.2 Global Implantable Cardioverter Defibrillators Market Revenue And Forecasts To 2025 (US$ Mn) 44
6.3.3 Transvenous Implantable Cardioverter Defibrillators 45
6.3.3.1 Overview 45
6.3.3.2 Global Transvenous Implantable Cardioverter Defibrillators Market Revenue And Forecasts To 2025 (US$ Mn) 45
6.3.4 Subcutaneous Implantable Cardioverter Defibrillators 46
6.3.4.1 Overview 46
6.3.4.2 Global Subcutaneous Implantable Cardioverter Defibrillators Market Revenue And Forecasts To 2025 (US$ Mn) 46
6.4 IMPLANTABLE CARDIAC PACEMAKERS MARKET 47
6.4.1 Overview 47
6.4.2 Global Implantable Cardiac Pacemakers Market Revenue and Forecasts To 2025 (US$ Mn) 47
6.5 VENTRICULAR ASSIST DEVICES MARKET 48
6.5.1 Overview 48
6.5.2 Global Ventricular Assist Device Market Revenue And Forecasts To 2025 (US$ Mn) 48
6.6 IMPLANTABLE HEART MONITORS/INSERTABLE LOOP RECORDERS MARKET 49
6.6.1 Overview 49
6.6.2 Global Implantable Heart Monitors/Insertable Loop Recorders Market Revenue And Forecasts To 2025 (US$ Mn) 49
6.7 NEUROSTIMULATORS MARKET 50
6.7.1 Overview 50
6.7.2 Global Neurostimulators Market Revenue And Forecasts To 2025 (US$ Mn) 50
6.8 IMPLANTABLE HEARING DEVICES MARKET 51
6.8.1 Overview 51
6.8.2 Global Implantable Hearing Devices Market Revenue And Forecasts To 2025 (US$ Mn) 51

7. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET ANALYSIS– BY END-USER 52
7.1 OVERVIEW 52
7.2 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES, BY END-USER 2017 & 2025 (%) 52
7.3 HOSPITALS MARKET 53
7.3.1 Overview 53
7.3.2 Global Hospitals Market Revenue And Forecasts To 2025 (US$ Mn) 53
7.4 AMBULATORY SURGERY CENTER MARKET 54
7.4.1 Overview 54
7.4.2 Global Ambulatory Surgery Center Market Revenue and Forecasts To 2025 (US$ Mn) 54
7.5 SPECIALTY CLINICS MARKET 55
7.5.1 Overview 55
7.5.2 Global Specialty Clinics Market Revenue And Forecasts To 2025 (US$ Mn) 55

8. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 56
8.1 OVERVIEW 56
8.2 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
8.3 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 57
8.3.1 North America Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 58
8.4 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 58
8.5 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 59
8.6 US ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
8.6.1 US Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 61
8.7 CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
8.7.1 Canada Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 63
8.8 MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
8.8.1 Mexico Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 65
9. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 66
9.1 OVERVIEW 66
9.2 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
9.3 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 68
9.3.1 Europe Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 68
9.4 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 69
9.5 EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 69
9.6 GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.6.1 Germany Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 71
9.6.2 Germany Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 71
9.6.3 Germany Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 72
9.6.4 Germany Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By End User (US$ Mn) 72
9.7 UK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
9.7.1 UK Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 73
9.7.2 UK Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 74
9.7.3 UK Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 74
9.7.4 UK Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By End User (US$ Mn) 74
9.8 FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
9.8.1 France Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 76
9.8.2 FRANCE Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 76
9.8.3 France Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 77
9.8.4 France Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By End User (US$ Mn) 77

10. ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 78
10.1 OVERVIEW 78
10.2 ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
10.3 ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 79
10.3.1 Asia Pacific Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 80
10.4 ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 81
10.5 ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 81
10.6 JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
10.6.1 Japan Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 82
10.6.2 Japan Active implantable medical devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 82
10.6.3 Japan Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 83
10.6.4 Japan Active implantable medical devices Market Revenue And Forecasts to 2025, By End user (US$ Mn) 83
10.7 CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
10.7.1 China Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 85
10.7.2 China Active implantable medical devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 86
10.7.3 China Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 86
10.7.4 China Active implantable medical devices Market Revenue And Forecasts to 2025, By End user (US$ Mn) 87
10.8 INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
10.8.1 India Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 88
10.8.2 India Active implantable medical devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 89
10.8.3 India Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 89
10.8.4 India Active implantable medical devices Market Revenue And Forecasts to 2025, By End user (US$ Mn) 90

11. MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 91
11.1 OVERVIEW 91
11.2 MIDDLE EAST AND AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
11.3 MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 92
11.3.1 Middle East & Africa Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 92
11.4 MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 93
11.5 MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 93
11.6 SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 93
11.6.1 Saudi Arabia Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 94
11.6.2 Saudi Arabia Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 95
11.7 U.A.E. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
11.7.1 U.A.E. Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 96
11.7.2 UAE Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 96
11.7.3 UAE Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 97
11.7.4 UAE Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By End User (US$ Mn) 97
11.8 SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 98
11.8.1 South Africa Active Implantable Medical Devices Market Revenue and Forecasts to 2025 (US$ Mn) 98
11.8.2 South Africa Active Implantable Medical Devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 98
11.8.3 South Africa Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 99

12. SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 100
12.1 OVERVIEW 100
12.2 SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
12.3 SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 101
12.3.1 South and Central America Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 102
12.4 SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY ENDUSER US$ MN) 102
12.5 SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY COUNTRY (2017 & 2025) (%) 102
12.6 BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 104
12.6.1 Brazil Active implantable medical devices Market Revenue And Forecasts to 2025, By Product (US$ Mn) 104
12.6.2 Brazil Implantable Cardioverter Defibrillators Market Revenue And Forecasts to 2025, By Type (US$ Mn) 105
12.6.3 Brazil Active implantable medical devices Market Revenue And Forecasts to 2025, By End user (US$ Mn) 106

13. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET –KEY COMPANY PROFILES 107
13.1 ABBOTT 107
13.1.1 Key Facts 107
13.1.2 Business Description 107
13.1.3 Financial Information 108
13.1.4 Product Portfolio 108
13.1.5 SWOT Analysis 109
13.1.6 Key Developments 110
13.2 MEDTRONIC 111
13.2.1 Key Facts 111
13.2.2 Business Description 111
13.2.3 Financial Information 112
13.2.4 Product Portfolio 112
13.2.5 SWOT Analysis 112
13.2.6 Key Developments 113
13.3 COCHLEAR LTD. 115
13.3.1 Key Facts 115
13.3.2 Business Description 115
13.3.3 Financial Information 116
13.3.4 Product Portfolio 116
13.3.5 SWOT Analysis 116
13.3.6 Key Developments 117
13.4 BOSTON SCIENTIFIC CORPORATION 119
13.4.1 Key Facts 119
13.4.2 Business Description 119
13.4.3 Financial Overview 119
13.4.4 Product Portfolio 120
13.4.5 Swot Analysis 120
13.4.6 Key Developments 121
13.5 BIOTRONIK SE&CO. KG 122
13.5.1 Key Facts 122
13.5.2 Business Description 122
13.5.3 Financial Overview 122
13.5.4 Product Portfolio 122
13.5.5 Swot Analysis 124
13.5.6 Key Developments 124
13.6 LIVANOVA PLC 126
13.6.1 Key Facts 126
13.6.2 Business Description 126
13.6.3 Financial Overview 127
13.6.4 Product Portfolio 127
13.6.5 Swot Analysis 127
13.6.6 Key Developments 127
13.7 MED-EL 128
13.7.1 Key Facts 128
13.7.2 Business Description 128
13.7.3 Financial Overview 129
13.7.4 Product Portfolio 129
13.7.5 Swot Analysis 129
13.7.6 Key Developments 130
13.8 SONOVA 131
13.8.1 Key Facts 131
13.8.2 Business Description 131
13.8.3 Financial Overview 132
13.8.4 Product Portfolio 132
13.8.5 SWOT Analysis 133
13.8.6 Key Developments 134
13.9 WILLIAM DEMANT HOLDING A/S 135
13.9.1 Key Facts 135
13.9.2 Business Description 135
Financial Overview 136
13.9.3 Product Portfolio 136
13.9.4 SWOT Analysis 137
13.9.5 Key Developments 138
13.10 NUROTRON BIOTECHNOLOGY CO. LTD. 139
13.10.1 Key Facts 139
13.10.2 Business Description 139
13.10.3 Financial Information 140
13.10.4 Product Portfolio 140
13.10.5 SWOT Analysis 140
13.10.6 Key Developments 141

14. APPENDIX 142
14.1 ABOUT THE INSIGHT PARTNERS 142
14.2 GLOSSARY OF TERMS 143
14.3 METHODOLOGY 144
14.3.1 Coverage 145
14.3.2 Secondary Research 146
14.3.3 Primary Research 146

LIST OF TABLES

TABLE 1. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 57
TABLE 2. NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 58
NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 58
TABLE 3. US ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 60
TABLE 4. US IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 61
TABLE 5. US ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 61
TABLE 6. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 62
TABLE 7. CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 63
TABLE 8. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 63
TABLE 9. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 64
TABLE 10. MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 65
TABLE 11. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 65
EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 68
TABLE 12. EUROPE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 68
TABLE 13. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 69
GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 71
TABLE 14. GERMANY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 72
TABLE 15. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 72
TABLE 16. UK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
TABLE 17. UK IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 74
TABLE 18. UK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 74
FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 76
TABLE 19. FRANCE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 77
TABLE 20. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 77
ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 79
TABLE 21. ASIA PACIFIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 80
ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 81
JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 83
TABLE 22. JAPAN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 83
JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 83
CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 86
TABLE 23. CHINA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 86
CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 87
INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 89
TABLE 24. INDIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 90
INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 90
MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 92
TABLE 25. MIDDLE EAST & AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 92
TABLE 26. MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 93
TABLE 27. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 94
TABLE 28. SAUDI ARABIA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 95
TABLE 29. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 95
TABLE 30. U.A.E. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 97
TABLE 31. UAE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 97
TABLE 32. U.A.E. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
TABLE 33. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 98
TABLE 34. SOUTH AFRICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 99
TABLE 35. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 99
TABLE 36. SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 101
TABLE 37. SOUTH AND CENTRAL AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 102
SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY ENDUSER 102
TABLE 38. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 105
TABLE 39. BRAZIL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 105
TABLE 40. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 106
TABLE 41. GLOSSARY OF TERMS, ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET 143

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2017 & 2025 20
FIGURE 2. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT, MARKET SHARE (%), 2017 21
FIGURE 3. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET BY END USER, MARKET SHARE (%), 2017 21
FIGURE 4. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION 23
FIGURE 5. ACTIVE IMPLANTABLE MEDICAL DEVICES SEGMENTATION, BY REGION 24
FIGURE 6. NORTH AMERICA PEST ANALYSIS 26
FIGURE 7. EUROPE PEST ANALYSIS 28
FIGURE 8. ASIA PACIFIC PEST ANALYSIS 30
FIGURE 9. MIDDLE EAST AND AFRICA PEST ANALYSIS 32
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 34
FIGURE 11. ACTIVE IMPLANTABLE MEDICAL DEVICES IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 39
FIGURE 12. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET – REVENUE FORECASTS AND ANALYSIS – 2017- 2025 40
FIGURE 13. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 41
FIGURE 14. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT 2017 & 2025 (%) 43
FIGURE 15. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
FIGURE 16. GLOBAL TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 17. GLOBAL SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
FIGURE 18. GLOBAL IMPLANTABLE CARDIAC PACEMAKERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 19. GLOBAL VENTRICULAR ASSIST DEVICE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 20. GLOBAL IMPLANTABLE HEART MONITORS/INSERTABLE LOOP RECORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
FIGURE 21. GLOBAL NEUROSTIMULATORS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 22. GLOBAL IMPLANTABLE HEARING DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 23. GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY END-USER 2017 & 2025 (%) 52
FIGURE 24. GLOBAL HOSPITALS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
FIGURE 25. GLOBAL AMBULATORY SURGERY CENTER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 26. GLOBAL SPECIALTY CLINICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
FIGURE 27. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OVERVIEW, BY COUNTRY (2017) 56
FIGURE 28. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 29. NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 59
FIGURE 30. US ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
FIGURE 31. CANADA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
FIGURE 32. MEXICO ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
FIGURE 33. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OVERVIEW, BY COUNTRY (2017) 66
FIGURE 34. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
FIGURE 35. EUROPE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY (2017 & 2025) 69
FIGURE 36. GERMANY ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
FIGURE 37. UK ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 38. FRANCE ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
FIGURE 39. ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OVERVIEW, BY COUNTRY (2017) 78
FIGURE 40. ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
FIGURE 41. ASIA PACIFIC ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 81
FIGURE 42. JAPAN ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
FIGURE 43. CHINA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
FIGURE 44. INDIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
FIGURE 1. MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OVERVIEW, BY COUNTRY (2017) 91
FIGURE 2. MIDDLE EAST & AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 91
FIGURE 3. MIDDLE EAST AND AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 93
FIGURE 4. SAUDI ARABIA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 94
FIGURE 5. U.A.E. ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 6. SOUTH AFRICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 98
FIGURE 7. SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET OVERVIEW, BY COUNTRY (2017) 100
FIGURE 8. SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
FIGURE 9. SOUTH AND CENTRAL AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SHARE, BY COUNTRY (2017 & 2025) (%) 102
FIGURE 10. BRAZIL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 104

The List of Companies

1. Medtronic
2. ABBOTT
3. Cochlear Ltd.
4. Boston Scientific Corporation
5. BIOTRONIK
6. MED-EL
7. SONOVA
8. William Demant Holding A/S
9. LivaNova PLC
10. Nurotron Biotechnology Co. Ltd.

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the active implantable medical device market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global active implantable medical device market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.